1-2 of 2
Paul T. Kirschmeier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity

Sangeetha Palakurthi, Mari Kuraguchi, Sima J. Zacharek, Enrique Zudaire, Wei Huang, Dennis M. Bonal, Jeffrey Liu, Abha Dhaneshwar, Kristin DePeaux, Martha R. Gowaski, Dyane Bailey, Samuel N. Regan, Elena Ivanova, Catherine Ferrante, Jessie M. English, Aditya Khosla, Andrew H. Beck, Julie A. Rytlewski, Catherine Sanders, Sylvie Laquerre, Mark A. Bittinger, Paul T. Kirschmeier, Kathryn Packman, Pasi A. Janne, Christopher Moy, Kwok-Kin Wong, Raluca I. Verona, Matthew V. Lorenzi
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2019) 7 (9): 1457–1471.
https://doi.org/10.1158/2326-6066.CIR-18-0595
Published: 03 September 2019
View article titled, The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity
Open the PDF for The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing

Patrick H. Lizotte, Ruey-Long Hong, Troy A. Luster, Megan E. Cavanaugh, Luke J. Taus, Stephen Wang, Abha Dhaneshwar, Naomi Mayman, Aaron Yang, Meghana Kulkarni, Lauren Badalucco, Erica Fitzpatrick, Hsiang-Fong Kao, Mari Kuraguchi, Mark Bittinger, Paul T. Kirschmeier, Nathanael S. Gray, David A. Barbie, Pasi A. Jänne
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2018) 6 (12): 1511–1523.
https://doi.org/10.1158/2326-6066.CIR-18-0193
Published: 03 December 2018
View article titled, A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing
Open the PDF for A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing in another window
Includes: Supplementary data